January 12-15, 2026 | San Francisco Marriott Marquis, CA
Delphian Therapeutics is a clinical-stage company targeting novel, multi-modal mechanisms to treat large pain and neurological disorders, starting with migraine, one of the world’s largest and most poorly-managed diseases.